US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CALCIMEDICA

1.51

+0.01000.67%

Post-market: 1.510.00000.00%16:00 EDT

Volume:7.61K

Turnover:11.47K

Market Cap:20.36M

PE:-1.24

High:1.53

Open:1.48

Low:1.48

Close:1.50

Loading ...

Overview Company News Filings

CalciMedica Inc - Daniel Geffken to Depart as Interim CFO

THOMSON REUTERS

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

CalciMedica Inc expected to post a loss of 50 cents a share - Earnings Preview

CalciMedica Is Maintained at Buy by HC Wainwright & Co.

CalciMedica’s Auxora Shows Promise in Acute Pancreatitis: Analyst Recommends Buy

CalciMedica price target lowered to $16 from $20 at H.C. Wainwright

CalciMedica Inc : H.c. Wainwright Cuts Target Price to $16 From $20

THOMSON REUTERS

Oppenheimer Sticks to Its Buy Rating for CalciMedica (CALC)

CalciMedica Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS

BRIEF-Calcimedica Announces Proposed Public Offering Of Common Stock

CalciMedica Announces Proposed Public Offering of Common Stock

THOMSON REUTERS

CalciMedica Announces Proposed Public Offering of Common Stock

CalciMedica’s Promising Phase 2b Trial Results for Auxora

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CALC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CALC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":1.51,"timestamp":1745870400000,"preClose":1.5,"halted":0,"volume":7607,"hourTrading":{"tag":"盘后","latestPrice":1.51,"preClose":1.51,"latestTime":"16:00 EDT","volume":156,"amount":235.56,"timestamp":1745870403270},"delay":0,"floatShares":5397734,"shares":13481917,"eps":-1.21822,"marketStatus":"Post-Mkt","change":0.01,"latestTime":"04-28 17:16:59 EDT","open":1.48,"high":1.5346,"low":1.48,"amount":11469.3908,"amplitude":0.0364,"askPrice":1.76,"askSize":100,"bidPrice":1.39,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.21822,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745884800000},"marketStatusCode":4,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":1.5,"postHourTrading":{"tag":"盘后","latestPrice":1.51,"preClose":1.51,"latestTime":"16:00 EDT","volume":156,"amount":235.56,"timestamp":1745870403270},"volumeRatio":0.287371},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","floatShares":5397734,"roa":"-94.61%","roe":"-121.42%","lyrEps":-1.21822,"volumeRatio":0.287371,"shares":13481917,"dividePrice":0,"high":1.5346,"amplitude":0.0364,"preClose":1.5,"low":1.48,"week52Low":1.43,"pbRate":"1.41","week52High":6.265,"institutionHeld":0,"latestPrice":1.51,"eps":-1.21822,"divideRate":0,"volume":7607,"delay":0,"ttmEps":-1.21822,"open":1.48,"prevYearClose":3.54,"prevWeekClose":1.5,"prevMonthClose":1.91,"prevQuarterClose":1.91,"fiveDayClose":1.547,"twentyDayClose":1.99,"sixtyDayClose":2.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CALC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2481087549","title":"CalciMedica Inc - Daniel Geffken to Depart as Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2481087549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481087549?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUABJRGZB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2481908022","title":"CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481908022","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481908022?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980800,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Nov. 7, 2024 /PRNewswire/ --CalciMedica, Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the appointment of Stephen Bardin as Chief Financial Officer and the planned departure of Daniel Geffken,Interim Chief Financial Officer upon filing the Company's third quarter financial statements. Mr. Bardin brings extensive capital raising, corporate development, and strategic finance expertise to CalciMedica, having most recently served as CFO of atai Life Sciences.\"CalciMedica has made impressive recent progress, delivering compelling clinical data for large and underserved patient populations,\" said Mr. Bardin. \"The CARPO Phase 2b data in patients with acute pancreatitis announced last month is promising and provides an optimistic readthrough to KOURAGE, CalciMedica's Phase 2 trial in acute kidney injury,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-strengthens-leadership-team-appointment-120000105.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-strengthens-leadership-team-appointment-120000105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","TISI","AP","CALC","BK4006","BK4120"],"gpt_icon":0},{"id":"2481600749","title":"CalciMedica Inc    expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481600749","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481600749?lang=en_us&edition=fundamental","pubTime":"2024-11-06 22:28","pubTimestamp":1730903304,"startTime":"0","endTime":"0","summary":"* CalciMedica Inc     is expected to show no change in quarterly revenue when it reports  results on November 7 (estimated) for the period ending September 30 2024   *    * LSEG's mean analyst estimat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CalciMedica Inc    expected to post a loss of 50 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2480301044","title":"CalciMedica Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2480301044","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480301044?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:11","pubTimestamp":1730722260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 04, 2024 07:11 ET (12:11 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2480306934","title":"CalciMedica’s Auxora Shows Promise in Acute Pancreatitis: Analyst Recommends Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2480306934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480306934?lang=en_us&edition=fundamental","pubTime":"2024-11-04 19:26","pubTimestamp":1730719569,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on CalciMedica (CALC – Research Report) today and set a price target of $16.00. Jo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/calcimedicas-auxora-shows-promise-in-acute-pancreatitis-analyst-recommends-buy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/calcimedicas-auxora-shows-promise-in-acute-pancreatitis-analyst-recommends-buy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2480930530","title":"CalciMedica price target lowered to $16 from $20 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2480930530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480930530?lang=en_us&edition=fundamental","pubTime":"2024-11-04 19:16","pubTimestamp":1730718970,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis lowered the firm’s price target on CalciMedica (CALC) to $16 from $20 and keeps a Buy rating on the shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-price-target-lowered-to-16-from-20-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-price-target-lowered-to-16-from-20-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2480530584","title":"CalciMedica Inc : H.c. Wainwright Cuts Target Price to $16 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2480530584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480530584?lang=en_us&edition=fundamental","pubTime":"2024-11-04 19:16","pubTimestamp":1730718964,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nFWN3MB057:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2479608588","title":"Oppenheimer Sticks to Its Buy Rating for CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479608588","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479608588?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:09","pubTimestamp":1730376597,"startTime":"0","endTime":"0","summary":"In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on CalciMedica (CALC – Research Report), with a price target o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-calcimedica-calc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-calcimedica-calc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","OPY"],"gpt_icon":0},{"id":"2479716458","title":"CalciMedica Announces Pricing of Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2479716458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479716458?lang=en_us&edition=fundamental","pubTime":"2024-10-31 10:11","pubTimestamp":1730340702,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nTUA3QDMCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2479476738","title":"BRIEF-Calcimedica Announces Proposed Public Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2479476738","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479476738?lang=en_us&edition=fundamental","pubTime":"2024-10-31 06:14","pubTimestamp":1730326496,"startTime":"0","endTime":"0","summary":"CalciMedica Inc   :   * CALCIMEDICA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCKSource text:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2479625765","title":"CalciMedica Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2479625765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479625765?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:51","pubTimestamp":1730321460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA4LWCS7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2479766871","title":"CalciMedica Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2479766871","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479766871?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:50","pubTimestamp":1730321400,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Oct. 30, 2024 /PRNewswire/ -- CalciMedica, Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announcedthat it has commenced an underwritten public offering of its shares of common stock.All of the shares to be sold in the underwritten public offering are to be sold by the Company. In connection with the proposed offering, the Company expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any sta","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-announces-proposed-public-offering-205000558.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-announces-proposed-public-offering-205000558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2479205006","title":"CalciMedica’s Promising Phase 2b Trial Results for Auxora","url":"https://stock-news.laohu8.com/highlight/detail?id=2479205006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479205006?lang=en_us&edition=fundamental","pubTime":"2024-10-30 19:48","pubTimestamp":1730288903,"startTime":"0","endTime":"0","summary":"CalciMedica ( ($CALC) ) just unveiled an announcement. CalciMedica, Inc. announced promising results from its Phase 2b CARPO trial of Auxora, a pot...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/calcimedicas-promising-phase-2b-trial-results-for-auxora?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/calcimedicas-promising-phase-2b-trial-results-for-auxora?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2479208040","title":"CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2479208040","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479208040?lang=en_us&edition=fundamental","pubTime":"2024-10-30 19:00","pubTimestamp":1730286000,"startTime":"0","endTime":"0","summary":"Statistically significant 100% reduction  in new-onset severe respiratory failure and 64.2% reduction  in new-onset persistent respiratory failure in combined high and medium dose Auxora patients versus combined low dose Auxora and placebo patients. Statistically significant stratified win ratio of 1.640  for high dose Auxora compared to placebo. Clinically meaningful reduction observed for high dose Auxora patients compared to placebo in additional key endpoints: new-onset necrotizing pancreatitis and time to medically indicated discharge. Conference call and webcast to review full data set from the Ph2b CARPO trial to be held at12 p.m. ET/9 a.m. PT. \"CARPO has delivered results that mirror those from previous Phase 2 trials of Auxora in other acute critical diseases and represents a significant step forward for the development of CRAC channel inhibitors in these diseases,\" said Sudarshan Hebbar, M.D., Chief Medical Officer ofCalciMedica. \"The CARPO results highlight Auxora's unique i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-present-breaking-positive-data-110000622.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-present-breaking-positive-data-110000622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CALC","AFG","AP","BK4006","BK4117","BK4107","BK4007"],"gpt_icon":0},{"id":"2479960452","title":"CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479960452","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479960452?lang=en_us&edition=fundamental","pubTime":"2024-10-29 04:05","pubTimestamp":1730145900,"startTime":"0","endTime":"0","summary":"Conference call and webcast to be held Wednesday, October 30, 2024 at 12 p.m. ET/ 9 a.m. PT. LAJOLLA, Calif., Oct. 28, 2024 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that it will host a call on Wednesday, October 30, 2024 at 12 p.m. ET/ 9 a.m. PT to review the full data set and win ratio analysis from the Company's Phase 2b CARPO trial of Auxora in acute pancreatitis  with accompanying systemic inflammatory response syndrome . Prof. Robert Sutton, University of Liverpool and Liverpool University Hospitals NHS Foundation Trust and chair of the Steering Committee for the CARPO trial, will deliver his plenary presentation from the American College of Gastroenterology  2024 Annual Scientific Meeting, entitled \"A Randomized, Double-Blind, Placebo Controlled Dose Ranging Study of Auxora i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-host-call-review-full-200500092.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-host-call-review-full-200500092.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4218","BK4181","BK4588","CALC","HST","BK4007","AP","BK4585","BK4006"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CALC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"CALC","fiscalQuarterEnding":"2024/12","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2024-11-13","symbol":"CALC","fiscalQuarterEnding":"2024/09","expectedEps":-0.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-08-12","symbol":"CALC","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2024-05-13","symbol":"CALC","fiscalQuarterEnding":"2024/03","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2024-03-28","symbol":"CALC","fiscalQuarterEnding":"2023/12","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"pre","actualEps":-0.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CALC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CALC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1734494400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CALC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CALC","date":"2025-04-25","current":-1.500724,"percent":0.863636,"low":-4.525842,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"high":-0.644854,"avg":-2.618509,"sd":0.960529,"marketCap":20559923},"quantilePoints":[{"date":"2024-01-05","current":-0.71129,"twenty":-0.71129,"median":-0.71129,"eighty":-0.71129,"marketCap":20480891},{"date":"2024-01-12","current":-0.644854,"twenty":-0.706809,"median":-0.663373,"eighty":-0.661399,"marketCap":18567932},{"date":"2024-01-19","current":-0.842346,"twenty":-0.707705,"median":-0.673245,"eighty":-0.662978,"marketCap":24254510},{"date":"2024-01-26","current":-1.017241,"twenty":-1.012132,"median":-0.706809,"eighty":-0.663373,"marketCap":29290430},{"date":"2024-02-02","current":-2.31259,"twenty":-1.35801,"median":-0.893146,"eighty":-0.671271,"marketCap":66588713},{"date":"2024-02-09","current":-1.906022,"twenty":-2.088582,"median":-1.017241,"eighty":-0.673245,"marketCap":54881987},{"date":"2024-02-16","current":-1.682223,"twenty":-2.119115,"median":-1.116267,"eighty":-0.690619,"marketCap":48437918},{"date":"2024-02-23","current":-1.643058,"twenty":-2.095833,"median":-1.634666,"eighty":-0.702071,"marketCap":47310206},{"date":"2024-03-01","current":-1.633733,"twenty":-2.020905,"median":-1.643058,"eighty":-0.709498,"marketCap":47041703},{"date":"2024-03-08","current":-1.652383,"twenty":-1.962717,"median":-1.659843,"eighty":-0.789924,"marketCap":47578709},{"date":"2024-03-15","current":-1.626273,"twenty":-1.923926,"median":-1.652383,"eighty":-0.903305,"marketCap":46826901},{"date":"2024-03-22","current":-1.428584,"twenty":-1.903784,"median":-1.64026,"eighty":-0.984091,"marketCap":41134640},{"date":"2024-03-28","current":-1.309808,"twenty":-1.864992,"median":-1.631159,"eighty":-1.013409,"marketCap":45001081},{"date":"2024-04-05","current":-1.359825,"twenty":-1.759493,"median":-1.626273,"eighty":-1.046819,"marketCap":46719500},{"date":"2024-04-12","current":-1.378581,"twenty":-1.683991,"median":-1.551673,"eighty":-1.099979,"marketCap":47363907},{"date":"2024-04-19","current":-1.25354,"twenty":-1.680731,"median":-1.469614,"eighty":-1.115647,"marketCap":43067861},{"date":"2024-04-26","current":-1.653672,"twenty":-1.680731,"median":-1.452232,"eighty":-1.163031,"marketCap":56815208},{"date":"2024-05-03","current":-1.87562,"twenty":-1.717206,"median":-1.540483,"eighty":-1.238535,"marketCap":64440690},{"date":"2024-05-10","current":-1.766209,"twenty":-1.764959,"median":-1.622543,"eighty":-1.25479,"marketCap":60681649},{"date":"2024-05-17","current":-3.903797,"twenty":-1.803163,"median":-1.628585,"eighty":-1.259167,"marketCap":58318824},{"date":"2024-05-24","current":-3.709686,"twenty":-1.90453,"median":-1.64026,"eighty":-1.263536,"marketCap":55418993},{"date":"2024-05-31","current":-4.076341,"twenty":-2.061189,"median":-1.652383,"eighty":-1.269686,"marketCap":60896452},{"date":"2024-06-07","current":-3.763144,"twenty":-2.28275,"median":-1.667303,"eighty":-1.292545,"marketCap":56217609},{"date":"2024-06-14","current":-3.626433,"twenty":-2.775108,"median":-1.674763,"eighty":-1.30043,"marketCap":54175287},{"date":"2024-06-21","current":-3.741558,"twenty":-3.626433,"median":-1.678493,"eighty":-1.306682,"marketCap":55895138},{"date":"2024-06-28","current":-2.266521,"twenty":-3.626433,"median":-1.678493,"eighty":-1.308558,"marketCap":33859554},{"date":"2024-07-05","current":-3.0652,"twenty":-3.626433,"median":-1.678493,"eighty":-1.309808,"marketCap":45791016},{"date":"2024-07-12","current":-3.396184,"twenty":-3.511308,"median":-1.683696,"eighty":-1.342725,"marketCap":50735586},{"date":"2024-07-15","current":-3.518504,"twenty":-3.517065,"median":-1.685169,"eighty":-1.342739,"marketCap":52562927},{"date":"2024-08-02","current":-3.223823,"twenty":-3.515626,"median":-1.694429,"eighty":-1.342753,"marketCap":48160698},{"date":"2024-08-09","current":-3.346156,"twenty":-3.502674,"median":-1.717881,"eighty":-1.345855,"marketCap":49988225},{"date":"2024-08-16","current":-3.501123,"twenty":-3.583261,"median":-1.750157,"eighty":-1.351697,"marketCap":44075639},{"date":"2024-08-23","current":-3.569438,"twenty":-3.582315,"median":-1.766209,"eighty":-1.354811,"marketCap":44935652},{"date":"2024-08-30","current":-3.67191,"twenty":-3.613882,"median":-1.801693,"eighty":-1.356667,"marketCap":46225670},{"date":"2024-09-06","current":-4.397752,"twenty":-3.637946,"median":-1.869368,"eighty":-1.357299,"marketCap":55363303},{"date":"2024-09-13","current":-3.552359,"twenty":-3.65203,"median":-1.906022,"eighty":-1.362326,"marketCap":44720648},{"date":"2024-09-20","current":-3.53528,"twenty":-3.640824,"median":-2.030976,"eighty":-1.373579,"marketCap":44505645},{"date":"2024-09-27","current":-3.859775,"twenty":-3.700214,"median":-2.125233,"eighty":-1.378581,"marketCap":48590705},{"date":"2024-10-04","current":-3.740224,"twenty":-3.708962,"median":-2.289556,"eighty":-1.380457,"marketCap":47085683},{"date":"2024-10-11","current":-3.371069,"twenty":-3.708962,"median":-2.722888,"eighty":-1.392648,"marketCap":42438390},{"date":"2024-10-18","current":-3.381146,"twenty":-3.700214,"median":-2.935837,"eighty":-1.41484,"marketCap":42565242},{"date":"2024-10-25","current":-3.53528,"twenty":-3.675822,"median":-3.058004,"eighty":-1.429837,"marketCap":44505645},{"date":"2024-10-31","current":-4.098876,"twenty":-3.6768,"median":-3.0652,"eighty":-1.43485,"marketCap":51600748},{"date":"2024-11-08","current":-3.744979,"twenty":-3.72195,"median":-3.072551,"eighty":-1.469614,"marketCap":47145546},{"date":"2024-11-15","current":-3.340773,"twenty":-3.734279,"median":-3.223823,"eighty":-1.536753,"marketCap":45394425},{"date":"2024-11-22","current":-3.420079,"twenty":-3.72195,"median":-3.270562,"eighty":-1.540483,"marketCap":46472038},{"date":"2024-11-29","current":-3.423065,"twenty":-3.714694,"median":-3.298285,"eighty":-1.558387,"marketCap":46512613},{"date":"2024-12-06","current":-2.966657,"twenty":-3.710325,"median":-3.295449,"eighty":-1.607623,"marketCap":40310931},{"date":"2024-12-13","current":-2.768218,"twenty":-3.706791,"median":-3.249448,"eighty":-1.624781,"marketCap":37614548},{"date":"2024-12-20","current":-2.748374,"twenty":-3.682653,"median":-3.194715,"eighty":-1.626273,"marketCap":37344910},{"date":"2024-12-27","current":-2.986501,"twenty":-3.673866,"median":-3.079903,"eighty":-1.62766,"marketCap":40580570},{"date":"2025-01-03","current":-3.264315,"twenty":-3.665078,"median":-3.095642,"eighty":-1.630644,"marketCap":44355506},{"date":"2025-01-10","current":-2.976579,"twenty":-3.653123,"median":-3.165095,"eighty":-1.634479,"marketCap":40445751},{"date":"2025-01-17","current":-3.145251,"twenty":-3.645198,"median":-3.087772,"eighty":-1.638582,"marketCap":42737676},{"date":"2025-01-24","current":-2.867437,"twenty":-3.640824,"median":-3.065538,"eighty":-1.643058,"marketCap":38962740},{"date":"2025-01-31","current":-2.52017,"twenty":-3.640824,"median":-3.058004,"eighty":-1.652383,"marketCap":34244069},{"date":"2025-02-07","current":-2.688843,"twenty":-3.640824,"median":-3.04842,"eighty":-1.652383,"marketCap":36535995},{"date":"2025-02-14","current":-2.649155,"twenty":-3.63798,"median":-3.022334,"eighty":-1.653672,"marketCap":35996718},{"date":"2025-02-21","current":-2.420951,"twenty":-3.628742,"median":-2.996423,"eighty":-1.664577,"marketCap":32895877},{"date":"2025-02-28","current":-2.2622,"twenty":-3.626433,"median":-2.986501,"eighty":-1.670287,"marketCap":30738770},{"date":"2025-03-07","current":-2.182824,"twenty":-3.621826,"median":-2.966657,"eighty":-1.674017,"marketCap":29660217},{"date":"2025-03-14","current":-1.885166,"twenty":-3.613842,"median":-2.897203,"eighty":-1.674763,"marketCap":25615642},{"date":"2025-03-21","current":-2.083605,"twenty":-3.598472,"median":-2.84934,"eighty":-1.677747,"marketCap":28312025},{"date":"2025-03-28","current":-2.053839,"twenty":-3.588224,"median":-2.832711,"eighty":-1.678493,"marketCap":27907568},{"date":"2025-04-04","current":-1.800869,"twenty":-3.578114,"median":-2.788062,"eighty":-1.678493,"marketCap":24671908},{"date":"2025-04-11","current":-1.456441,"twenty":-3.570753,"median":-2.763257,"eighty":-1.678493,"marketCap":19953237},{"date":"2025-04-17","current":-1.515486,"twenty":-3.564314,"median":-2.743413,"eighty":-1.673271,"marketCap":20762152},{"date":"2025-04-25","current":-1.500724,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"marketCap":20559923}],"updateTime":1745837587007}}}